Imagine a simple stroll down the hallway revealing the future of a patient’s recovery from major hip surgery—sounds almost too straightforward to be true, doesn’t it? Yet, a pioneering study from Kyushu University in Japan has uncovered that the speed at which someone walks before undergoing total
Diving into the complex world of microbiome research, I had the privilege of speaking with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan has been instrumental in
Imagine a world where life-altering therapies for genetic disorders, cancer, and infectious diseases are not just a distant dream but a tangible reality, delivered precisely to the cells that need them most. RNA therapeutics hold this transformative promise, yet their potential remains locked
Ivan Kairatov has spent years at the crossroads of oncology and drug development, translating trial signals into day-to-day decisions for patients with localized prostate cancer. In this conversation, he unpacks new evidence showing that most of the value from androgen deprivation therapy (ADT)
Rising demand, tighter budgets, and complex patients have pushed cardiovascular imaging from supporting act to central protagonist, and that shift is on full display in Vienna as echo, CMR, CT, and nuclear cardiology share one stage from December 11–13. Congress organizers set a clear purpose:
I'm thrilled to be speaking with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development has positioned him at the forefront of cutting-edge cancer treatment technologies. Today, we’ll dive into the groundbreaking work on nanodots made from molybdenum
